PharmaShots | Incisive News in 3 Shots

Subscribe Now

ADC program

Exelixis Signs an Exclusive Option and License Agreement with Iconic Therapeutics for Advancing ADC Program

Exelixis Signs an Exclusive Option and License Agreement with Iconic Therapeutics for Advancing ADC Program

May 17, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us